Viewing StudyNCT06305234



Ignite Creation Date: 2024-05-06 @ 8:14 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06305234
Status: RECRUITING
Last Update Posted: 2024-03-12
First Post: 2024-01-30

Brief Title: A Long Term Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU PALisade
Sponsor: BioMarin Pharmaceutical
Organization: BioMarin Pharmaceutical

Conditions & Keywords Data

Conditions:
Name
Phenylketonuria PKU
Keywords:
Name View
inflammatory assessment View
PKU View
Phenylketonuria View
Palynziq View
pegvaliase View
observational View
safety study View
immunogenicity assessment View